Professor Meir Pugatch spoke together with Tom Donohue (President and CEO of the U.S. Chamber of Commerce), David Hirschmann (President and CEO of the U.S. Chamber of Commerce Global Intellectual Property Center) and former Director of the United States Patent and Trademark Office, David Kappos, at the launch of the fifth edition of the U.S. Chamber’s International IP Index in Washington D.C earlier this week.
Continue Reading →
Posted by:
Today Pugatch Consilium releases Generic drugs appraisal and approval: departing from the ‘one-size-fits-all’ approach.
Generic medicines – follow-on versions of off-patent innovative medicines – are designed to be interchangeable to the innovative reference product. As more sophisticated and complex medicines are developed, securing the safe and effective use of their follow-on products becomes increasingly challenging.
This report zeroes in on the existing gaps and challenges within the ‘one-size-fits-all’ model of generic drugs approval vis-à-vis two particularly complex drugs: Narrow Therapeutic Index (NTI ...
Continue Reading →Today Semana Magazine, Colombia’s leading and international prize-winning magazine, published the article: ¿Cómo ser más competitivo? (How to increase competitiveness?) following an exclusive interview with Ma’ayan Laufer, a senior consultant at Pugatch Consilium. The interview took place last week, right after the launch of Pugatch Consilium’s recent report: “Challenges and Opportunities – Developing the Biotechnology Sector in Colombia” at the Bionovo conference in Bogotá, Colombia [BioNovo]
The key findings of the report, that Colombia could see over 100 new clinical ...
Continue Reading →
Today Pugatch Consilium releases Challenges and Opportunities – Developing the Biotechnology Sector in Colombia.
The purpose of this report is to, firstly, give a comparative overview of the biotechnology sector in Colombia and, secondly, provide an estimate of how an improvement to Colombia’s policy environment can result in higher biotechnology outputs including rates of biomedical FDI and clinical trials.
The report maps the current policy environment as it relates to biotechnology in Colombia and gives a detailed comparison on key major biotechnology ...
Continue Reading →Posted by:
Pugatch Consilium has launched the third edition of the Biopharmaceutical Competitiveness & Investment (BCI) Survey: The Race for Biopharmaceutical Innovation.
A global executive opinion survey and index of economies’ attractiveness for biomedical investment, in 2016 the BCI covers 28 strategic markets and gauges individual markets in relation to others with similar levels of development. The study was released in Washington DC and Ottawa, Canada, with other local and regional launches to take place throughout the remainder of the year.
Key findings of the ...
Continue Reading →
Pugatch Consilium’s Biopharmaceutical Competitiveness & Investment Survey – known as the BCI – gained much attention when presented by Taiwan’s Vice-President, Chien-Jen Chen in his opening remarks at the BioBusiness Asia Conference which took place last week in Taipei.
VP Chen discussed the growth and development of Taiwan’s biotech industry, the challenges that still remain, and the new governmental policies in six areas of priorities in the biomedical industry, including increased efforts to harmonize the IP and legislative environments with international ...
Continue Reading →
Commissioned by the Biotechnology Industry Organization and authored by Pugatch Consilium this series of reports seek to provide an overview of those national innovation strategies, policies and best practices that have been successful in creating an environment in which biotechnologies and biotechnological innovation can flourish.
This year Building the Bioeconomy has grown from thirteen economies to sixteen, adding Colombia, Israel and Japan. As in previous editions the sample of economies is geographically and economically diverse with a mix of high-income mature ...
Continue Reading →
More in number and more draconian – Localization barriers have grown in number and intensity over the last decade. Our new study – Separating Fact from Fiction: How Localization Barriers Fail Where Positive Non-discriminatory Incentives Succeed – finds that over the last 5-10 years industrial aspirations and concern over their dependence on global supply chains have led many emerging markets to seek to bolster or create indigenous sectors through introducing protectionist-like measures.
However, the study also finds that restrictive and punitive ...
Continue Reading →
Dr. David Torstensson spoke yesterday at the Mexican Senate and IMPI (the Mexican industrial property institute) event entitled: “First day for an original Mexico – promoting the culture of industrial property” (Primera Jornada por un México Original: Promoviendo la cultura de la propiedad industrial). With the aim of increasing awareness to the importance of IP protection to economic development, numerous representatives of public and private institutions analyzed the current state of the Mexican IP environment, with a particular focus on ...
Continue Reading →Posted by:
India continues to sit on the sidelines of international intellectual property laws.
Article by Dr. David Torstensson, a partner at Pugatch Consilium and part of the team that took part in the construction and authorship of the US Chamber’s International IP Index.
Read more at The Financial Express
Continue Reading →